NURONeuroMetrix, Inc.

Nasdaq neurometrix.com


$ 3.86 $ 0.02 (0.52 %)    

Wednesday, 22-May-2024 15:59:28 EDT
QQQ $ 454.82 $ -0.09 (-0.02 %)
DIA $ 398.57 $ -2.12 (-0.53 %)
SPY $ 530.36 $ -1.53 (-0.29 %)
TLT $ 91.26 $ 0.11 (0.12 %)
GLD $ 225.37 $ -4.12 (-1.84 %)
$ 3.84
$ 3.86
$ 0.00 x 0
$ 0.00 x 0
$ 3.86 - $ 3.86
$ 2.70 - $ 9.68
9,931
na
6.96M
$ 1.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-01-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 03-22-2023 12-31-2022 10-K
7 10-20-2022 09-30-2022 10-Q
8 07-21-2022 06-30-2022 10-Q
9 04-26-2022 03-31-2022 10-Q
10 01-28-2022 12-31-2021 10-K
11 10-21-2021 09-30-2021 10-Q
12 07-22-2021 06-30-2021 10-Q
13 04-22-2021 03-31-2021 10-Q
14 01-29-2021 12-31-2020 10-K
15 10-22-2020 09-30-2020 10-Q
16 07-23-2020 06-30-2020 10-Q
17 04-23-2020 03-31-2020 10-Q
18 01-28-2020 12-31-2019 10-K
19 10-17-2019 09-30-2019 10-Q
20 07-18-2019 06-30-2019 10-Q
21 04-25-2019 03-31-2019 10-Q
22 01-24-2019 12-31-2018 10-K
23 10-17-2018 09-30-2018 10-Q
24 07-19-2018 06-30-2018 10-Q
25 04-20-2018 03-31-2018 10-Q
26 02-08-2018 12-31-2017 10-K
27 10-20-2017 09-30-2017 10-Q
28 07-20-2017 06-30-2017 10-Q
29 04-20-2017 03-31-2017 10-Q
30 02-09-2017 12-31-2016 10-K
31 10-20-2016 09-30-2016 10-Q
32 07-21-2016 06-30-2016 10-Q
33 04-21-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 10-22-2015 09-30-2015 10-Q
36 07-23-2015 06-30-2015 10-Q
37 04-24-2015 03-31-2015 10-Q
38 02-25-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-24-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 neurometrix-q1-eps-167-down-from-164-yoy-sales-109m-down-from-173m-yoy

NeuroMetrix (NASDAQ:NURO) reported quarterly losses of $(1.67) per share. This is a 1.83 percent decrease over losses of $(1.64...

 neurometrix-announces-that-over-2000-patients-with-fibromyalgia-have-been-prescribed-quell-fibromyalgia

NeuroMetrix, Inc. (NASDAQ:NURO) today announced that over 2000 fibromyalgia patients have been prescribed Quell Fibromyalgia si...

 echo-lake-capital-calls-for-the-liquidation-of-neurometrix-inc-notes-tremendous-destruction-of-shareholder-value-under-cos-leadership-sees-no-reason-for-co-to-remain-public

- Stock trades significantly below its net cash per share- Questions the Board's ability and/or desire to create shareholde...

 neurometrix-q4-eps-143-down-from-073-yoy-sales-132m-down-from-185m-yoy

NeuroMetrix (NASDAQ:NURO) reported quarterly losses of $(1.43) per share. This is a decrease over losses of $(0.73) per share f...

 earnings-scheduled-for-february-22-2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

 neurometrix-13g-filing-shows-rs-fund-lp-reported-a-144-stake-in-the-co-as-of-february-13-2024

- SEC Filing 

 neurometrix-announces-review-of-strategic-options-to-promote-growth-of-its-quell-neuromodulation-and-dpncheck-neurodiagnostic-businesses-and-to-maximize-shareholder-value

NeuroMetrix, Inc. (NASDAQ:NURO), a commercial stage medical device company focused on reducing the impact of neurological disor...

 neurometrix-reported-the-recent-presentation-of-data-from-a-clinical-trial-of-quell-wearable-neuromodulation-technology-in-patients-with-post-acute-covid-19-syndrome

The presentation was made at the National Science Foundation (NSF) funded Center to Stream Healthcare In Place (C2SHIP) annual ...

 neurometrix-shares-resume-trade
NeuroMetrix Shares Resume Trade
11/22/2023 14:00:29

 neurometrix-announces-1-for-8-reverse-stock-split

NeuroMetrix, Inc. (NASDAQ: NURO) today announced that it will effect a one-for-eight reverse split of its common stock, effecti...

 earnings-scheduled-for-october-26-2023

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on re...

 neurometrix-q3-gaap-eps-021-up-from-023-yoy-sales-120m-down-from-197m-yoy

NeuroMetrix (NASDAQ:NURO) reported quarterly losses of $(0.21) per share. This is a 8.7 percent increase over losses of $(0.23)...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION